Back to UBS Group AG UBS Group AG

PLXPQPLXPQ
18 quarters

Position history for UBS Group AGUBS Group AG's holdings in PLX PHARMA INC

No. Ubs exited its PLXPQ (PLX Pharma) position in Q2 2023. Its Q1 2023 13F listed 51,213 shares worth $6,657. Ubs already held PLXPQ in its Q1 2019 13F, the earliest on record, and held it in 17 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$16,000

Total Shares Change

-2,917

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q2
Latest
Exited
0
-100.0%
$00.0%—
0
2023-Q1
Decreased
51,213
-38.8%
$6,6570.0%—
0
2022-Q4
Increased
83,723
+49.6%
$13,3960.0%—
17
2022-Q3
Increased
55,971
+9.5%
$36,0000.0%—
15
2022-Q2
Unchanged
51,132
0.0%
$124,0000.0%—
0
2022-Q1
Decreased
51,132
-12.5%
$207,0000.0%—
0
2021-Q4
Increased
58,423
+46.1%
$468,0000.0%—
33
2021-Q3
Increased
39,998
+135.1%
$772,0000.0%—
40
2021-Q2
Increased
17,012
+22.8%
$235,0000.0%—
28
2021-Q1
Increased
13,851
+497.0%
$125,0000.0%—
24
2020-Q4
Decreased
2,320
-38.8%
$13,0000.0%—
0
2020-Q3
Increased
3,793
+260.2%
$12,0000.0%—
19
2020-Q2
Decreased
1,053
-42.6%
$3,0000.0%—
0
2020-Q1
Increased
1,834
+74.2%
$4,0000.0%—
15
2019-Q4
Unchanged
1,053
0.0%
$5,0000.0%—
0
2019-Q3
Decreased
1,053
-70.3%
$5,0000.0%—
0
2019-Q2
Increased
3,544
+21.5%
$26,0000.0%—
16
2019-Q1
First report
2,917
-
$16,0000.0%—
0

Other major holders of PLXPQ: MSD Partners, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used